# Eikon Therapeutics, Inc.: Form 8-K, filed Aug 3, 2026

- Company: [Eikon Therapeutics, Inc.](/companies/eikn.md) (CIK 1861123)
- Form: 8-K
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 16:39 ET
- Period: 2026-07-31
- Accession: 0001193125-26-330710
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1861123/000119312526330710/eikn-20260731.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1861123/000119312526330710/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1861123/000119312526330710/eikn-20260731.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-330710. Last ingested by Listed: Nov 12, 2026, 17:35 ET. No prices; not investment advice.